Page last updated: 2024-08-18

pyrroles and an 207

pyrroles has been researched along with an 207 in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (30.00)18.2507
2000's7 (70.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Groot, K; Koppan, M; Kovacs, M; Nagy, A; Schally, AV1
Arencibia, JM; Groot, K; Halmos, G; Koppán, M; Nagy, A; Plonowski, A; Schally, AV1
Nagy, A; Schally, AV; Szepeshazi, K1
Nagy, A; Plonowski, A; Schally, AV1
Arencibia, JM; Groot, K; Halmos, G; Kahán, Z; Nagy, A; Schally, AV1
Arencibia, JM; Bajo, AM; Chatzistamou, I; Krupa, M; Nagy, A; Schally, AV1
Nagy, A; Schally, AV1
Halmos, G; Kanashiro, CA; Nagy, A; Schally, AV; Stangelberger, A; Szepeshazi, K1
Halmos, G; Schally, AV; Szepeshazi, K1
Halmos, G; Schally, AV; Seitz, S; Szepeshazi, K; Treszl, A1

Reviews

1 review(s) available for pyrroles and an 207

ArticleYear
Targeting of cytotoxic luteinizing hormone-releasing hormone analogs to breast, ovarian, endometrial, and prostate cancers.
    Biology of reproduction, 2005, Volume: 73, Issue:5

    Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Doxorubicin; Endometrial Neoplasms; Epithelial Cells; Female; Gonadotropin-Releasing Hormone; Humans; Male; Ovarian Neoplasms; Prostatic Neoplasms; Pyrroles; Receptors, LHRH

2005

Other Studies

9 other study(ies) available for pyrroles and an 207

ArticleYear
Recovery of pituitary function after treatment with a targeted cytotoxic analog of luteinizing hormone-releasing hormone.
    Proceedings of the National Academy of Sciences of the United States of America, 1997, Feb-18, Volume: 94, Issue:4

    Topics: Animals; Antineoplastic Agents; Body Weight; Cytotoxins; Doxorubicin; Female; Gonadotropin-Releasing Hormone; Growth Hormone; Luteinizing Hormone; Menstrual Cycle; Pituitary Function Tests; Pituitary Gland, Anterior; Pyrroles; Rats; Rats, Sprague-Dawley; Thyrotropin

1997
Targeted cytotoxic analog of luteinizing hormone-releasing hormone AN-207 inhibits the growth of PC-82 human prostate cancer in nude mice.
    The Prostate, 1999, Feb-01, Volume: 38, Issue:2

    Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Doxorubicin; Drug Delivery Systems; Gonadotropin-Releasing Hormone; Humans; Male; Mice; Mice, Nude; Models, Chemical; Polymerase Chain Reaction; Prostatic Neoplasms; Pyrroles; Receptors, LHRH; Transplantation, Heterologous; Tumor Cells, Cultured

1999
Effective treatment of advanced estrogen-independent MXT mouse mammary cancers with targeted cytotoxic LH-RH analogs.
    Breast cancer research and treatment, 1999, Volume: 56, Issue:3

    Topics: Animals; Antineoplastic Agents; Cell Division; Doxorubicin; Drug Delivery Systems; Estrogens; Female; Gonadotropin-Releasing Hormone; Growth Inhibitors; Injections, Intravenous; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Neoplasms, Hormone-Dependent; Pyrroles

1999
Stability of cytotoxic luteinizing hormone-releasing hormone conjugate (AN-152) containing doxorubicin 14-O-hemiglutarate in mouse and human serum in vitro: implications for the design of preclinical studies.
    Proceedings of the National Academy of Sciences of the United States of America, 2000, Jan-18, Volume: 97, Issue:2

    Topics: Adult; Animals; Antineoplastic Agents; Bombesin; Carboxylesterase; Carboxylic Ester Hydrolases; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Doxorubicin; Drug Evaluation, Preclinical; Drug Interactions; Drug Stability; Gonadotropin-Releasing Hormone; Half-Life; Humans; Hydrolysis; Isoflurophate; Male; Mice; Mice, Nude; Nitrophenols; Paraoxon; Pyrroles; Weight Loss

2000
Administration of a targeted cytotoxic analog of luteinizing hormone-releasing hormone inhibits growth of estrogen-independent MDA-MB-231 human breast cancers in nude mice.
    Breast cancer research and treatment, 2000, Volume: 59, Issue:3

    Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Breast Neoplasms; Disease Models, Animal; DNA Primers; Doxorubicin; Drug Delivery Systems; Female; Gonadotropin-Releasing Hormone; Humans; Mice; Mice, Nude; Neoplasm Transplantation; Pyrroles; Radioligand Assay; Receptors, LHRH; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Specific Pathogen-Free Organisms; Tumor Cells, Cultured

2000
Effective treatment of experimental ES-2 human ovarian cancers with a cytotoxic analog of luteinizing hormone-releasing hormone AN-207.
    Anti-cancer drugs, 2002, Volume: 13, Issue:9

    Topics: Animals; Antineoplastic Agents; Doxorubicin; Drug Evaluation, Preclinical; ErbB Receptors; Female; Gonadotropin-Releasing Hormone; Humans; Mice; Mice, Nude; Neoplasm Transplantation; Ovarian Neoplasms; Pyrroles; Receptor, ErbB-2; Receptors, LHRH; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Treatment Outcome; Tumor Cells, Cultured

2002
Inhibition of human experimental prostate cancers by a targeted cytotoxic luteinizing hormone-releasing hormone analog AN-207.
    The Prostate, 2006, Feb-01, Volume: 66, Issue:2

    Topics: Androgens; Animals; Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Disease Progression; Doxorubicin; Gonadotropin-Releasing Hormone; Humans; Male; Mice; Mice, Nude; Neoplasm Transplantation; Prostatic Neoplasms; Proto-Oncogene Proteins c-bcl-2; Pyrroles; Receptors, LHRH; RNA, Messenger; Transplantation, Heterologous; Triptorelin Pamoate

2006
LH-RH receptors in human colorectal cancers: unexpected molecular targets for experimental therapy.
    International journal of oncology, 2007, Volume: 30, Issue:6

    Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Proliferation; Colorectal Neoplasms; Doxorubicin; Gonadotropin-Releasing Hormone; Humans; Male; Mice; Mice, Nude; Pyrroles; Receptors, LHRH; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger

2007
Therapy of experimental hepatic cancers with cytotoxic peptide analogs targeted to receptors for luteinizing hormone-releasing hormone, somatostatin or bombesin.
    Anti-cancer drugs, 2008, Volume: 19, Issue:4

    Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Bombesin; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Doxorubicin; Gonadotropin-Releasing Hormone; Humans; Immunohistochemistry; Liver Neoplasms; Mice; Mice, Nude; Neoplasm Transplantation; Pyrroles; Radioligand Assay; Receptors, Bombesin; Receptors, LHRH; Receptors, Somatostatin; Transplantation, Heterologous

2008